Hosein Kouros-Mehr
Hosein Kouros-Mehr
Vice President, Sana Biotechnology
Verified email at
Cited by
Cited by
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland
H Kouros-Mehr, EM Slorach, MD Sternlicht, Z Werb
Cell 127 (5), 1041-1055, 2006
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays
S Nishizuka, L Charboneau, L Young, S Major, WC Reinhold, M Waltham, ...
Proceedings of the National Academy of Sciences 100 (24), 14229-14234, 2003
GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model
H Kouros-Mehr, SK Bechis, EM Slorach, LE Littlepage, M Egeblad, ...
Cancer cell 13 (2), 141-152, 2008
Hormonal and local control of mammary branching morphogenesis
MD Sternlicht, H Kouros‐Mehr, P Lu, Z Werb
Differentiation 74 (7), 365-381, 2006
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin
MD Sternlicht, SW Sunnarborg, H Kouros-Mehr, Y Yu, DC Lee, Z Werb
Oxford University Press for The Company of Biologists Limited 132 (17), 3923 …, 2005
Candidate regulators of mammary branching morphogenesis identified by genome‐wide transcript analysis
H Kouros‐Mehr, Z Werb
Developmental dynamics: an official publication of the American Association …, 2006
Genomic characterization of the human heterotrimeric G protein α, β, and γ subunit genes
EH Hurowitz, JM Melnyk, YJ Chen, H Kouros-Mehr, MI Simon, H Shizuya
DNA research 7 (2), 111-120, 2000
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel
KJ Bussey, K Chin, S Lababidi, M Reimers, WC Reinhold, WL Kuo, ...
Molecular cancer therapeutics 5 (4), 853-867, 2006
GATA-3 and the regulation of the mammary luminal cell fate
H Kouros-Mehr, J Kim, SK Bechis, Z Werb
Current opinion in cell biology 20 (2), 164-170, 2008
Identification of druggable cancer driver genes amplified across TCGA datasets
Y Chen, J McGee, X Chen, TN Doman, X Gong, Y Zhang, N Hamm, X Ma, ...
PloS one 9 (5), e98293, 2014
The development and applications of the bacterial artificial chromosome cloning system
H Shizuya, H Kouros-Mehr
The Keio journal of medicine 50 (1), 26-30, 2001
Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale
A Bagri, H Kouros-Mehr, KG Leong, GD Plowman
Trends in molecular medicine 16 (3), 122-132, 2010
Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping
WC Reinhold, H Kouros-Mehr, KW Kohn, AK Maunakea, S Lababidi, ...
Cancer research 63 (5), 1000-1011, 2003
The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer ProgressionZNF217 Overexpression Promotes Malignancy
LE Littlepage, AS Adler, H Kouros-Mehr, G Huang, J Chou, SR Krig, ...
Cancer discovery 2 (7), 638-651, 2012
Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells
WC Reinhold, MA Reimers, AK Maunakea, S Kim, S Lababidi, U Scherf, ...
Molecular cancer therapeutics 6 (2), 391-403, 2007
Identification of non-functional human VNO receptor genes provides evidence for vestigiality of the human VNO
H Kouros-Mehr, S Pintchovski, J Melnyk, YJ Chen, C Friedman, B Trask, ...
Chemical senses 26 (9), 1167-1174, 2001
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene
YW Phua, A Nguyen, DL Roden, B Elsworth, N Deng, I Nikolic, J Yang, ...
Breast Cancer Research 17 (1), 1-18, 2015
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model
C Franci, J Zhou, Z Jiang, Z Modrusan, Z Good, E Jackson, ...
PloS one 8 (3), e58183, 2013
AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies
SM Major, S Nishizuka, D Morita, R Rowland, M Sunshine, ...
BMC bioinformatics 7 (1), 1-10, 2006
Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFss
IM Chu, WC Lai, O Aprelikova, LH El Touny, H Kouros-Mehr, JE Green
PLoS One 8 (4), e61125, 2013
The system can't perform the operation now. Try again later.
Articles 1–20